To summarize, our study aimed to unveil the therapeutic effect of curcumin in alleviating IL-18-p-SMAD2/3–induced cardiac fibrosis subsequent to MI, which is mediated by the inhibition of inflammation-induced macrophage-fibroblast crosstalk. This evidence concerns the gene IL18 and myocardial infarction.